Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study
暂无分享,去创建一个
P. Schirmacher | M. Dietel | Michael Thomas | U. Zirrgiebel | W. Eberhardt | W. Schuette | Lars Muehlenhoff